天美传媒

Journal of Clinical Diabetes
天美传媒 Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Clin Diabetes 2024, Vol 8(1): 210

Poor Health-Related Quality of Life Associated with Diabetic Patients on Anticonvulsant Medication: A Blinder-Oaxaca Decomposition

Ekwu Boniface Bradford Ochigbo*
Center for the Evaluation of Value and Risk (CEVR), Institute for Clinical Research & Health Policy Studies (ICRHPS), Tufts Medical Center, 800 Washington Street, Boston, MA 02111, U.S.A
*Corresponding Author : Ekwu Boniface Bradford Ochigbo, Center for the Evaluation of Value and Risk (CEVR), Institute for Clinical Research & Health Policy Studies (ICRHPS), Tufts Medical Center, 800 Washington Street, Boston, MA 02111, U.S.A, Email: bochigbo@tuftsmedicalcenter.org

Received Date: Nov 30, 2023 / Accepted Date: Dec 26, 2023 / Published Date: Jan 02, 2024

Abstract

This study evaluates the potential to improve the quality of life for diabetic patients with comorbidities that warrant adjunctive anticonvulsant medication treatment. It explores the extent to which differences in person-level characteristics contribute to poor health related quality of life (HRQoL), and the gap in HRQoL in optimally treated diabetic neuropathy patients.

It employs a retrospective cohort design utilizing data from the Medical Expenditure Panel Survey (MEPS) to estimate HRQol in patients with diabetes mellitus. It applies the mental component scores (mcs) and the physical component scores (pcs) from the 12 item Short Form Survey (SF12) questionnaire to estimate differences in patient overall health and quality of life among diabetics on anticonvulsant medication. A Blinder Oaxaca regression decomposition analysis performed from post linear regression quantified how much of the difference between mcs and pcs scores are explained by patient characteristics such as age, gender, race, employment, and other chronic conditions among diabetic patients on anticonvulsant medication in comparison to the general diabetic patient population.

The results reveal that ceteris paribus, diabetic patients on anticonvulsant therapy were more likely to have lower pcs and mcs scores (β=−5.24; P<0.001, β=−3.151; P<0.01) respectively, demonstrating an overall lower HRQoL. About 80% of the difference in pcs scores were unexplained by observed patient characteristics and may be intrinsic to disease complication or gaps in treatment. The study shows how modifiable and non-modifiable patient characteristics explain health status differences, and how addressing patient needs depends on implementing robust treatment and intervention policies both within and beyond the healthcare sector.

Citation: Ochigbo EBB (2024) Poor Health-Related Quality of Life Associated withDiabetic Patients on Anticonvulsant Medication: A Blinder-Oaxaca Decomposition.J Clin Diabetes 8: 210.

Copyright: © 2024 Ochigbo EBB. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top